Mediwound Ownership
| MDWD Stock | USD 18.29 0.12 0.65% |
Shares in Circulation | First Issued 2012-12-31 | Previous Quarter 9.3 M | Current Value 10.5 M | Avarage Shares Outstanding 7.4 M | Quarterly Volatility 20 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Mediwound |
Mediwound Stock Ownership Analysis
About 20.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 2.91. Mediwound had not issued any dividends in recent years. The entity had 1:7 split on the 20th of December 2022. MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel. Mediwound operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 77 people. To find out more about Mediwound contact the company at 972 7 797 14100 or learn more at https://www.mediwound.com.Besides selling stocks to institutional investors, Mediwound also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Mediwound's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Mediwound's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Mediwound Quarterly Liabilities And Stockholders Equity |
|
About 20.0% of Mediwound are currently held by insiders. Unlike Mediwound's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Mediwound's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Mediwound's insider trades
Mediwound Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Mediwound is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Mediwound backward and forwards among themselves. Mediwound's institutional investor refers to the entity that pools money to purchase Mediwound's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Northern Trust Corp | 2024-09-30 | 74.4 K | State Street Corp | 2024-09-30 | 66.3 K | Dafna Capital Management Llc | 2024-09-30 | 64.5 K | J. Goldman & Co Lp | 2024-09-30 | 59 K | Vanguard Group Inc | 2024-09-30 | 56 K | Legato Capital Management Llc | 2024-09-30 | 39.1 K | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 38.6 K | Prescott Group Capital Management Llc | 2024-09-30 | 37.8 K | Renaissance Technologies Corp | 2024-09-30 | 34.4 K | Investors Finance Co Plc | 2024-09-30 | 872.1 K | Yelin Lapidot Holdings Management Ltd | 2024-09-30 | 750.7 K |
Mediwound Outstanding Bonds
Mediwound issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Mediwound uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Mediwound bonds can be classified according to their maturity, which is the date when Mediwound has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Mediwound Corporate Filings
6K | 8th of January 2025 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
13A | 23rd of October 2024 An amended filing to the original Schedule 13G | ViewVerify |
13A | 1st of October 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
| 9th of September 2024 Other Reports | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Mediwound is a strong investment it is important to analyze Mediwound's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Mediwound's future performance. For an informed investment choice regarding Mediwound Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mediwound. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. For information on how to trade Mediwound Stock refer to our How to Trade Mediwound Stock guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mediwound. If investors know Mediwound will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mediwound listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.91) | Revenue Per Share | Quarterly Revenue Growth 0.061 | Return On Assets | Return On Equity |
The market value of Mediwound is measured differently than its book value, which is the value of Mediwound that is recorded on the company's balance sheet. Investors also form their own opinion of Mediwound's value that differs from its market value or its book value, called intrinsic value, which is Mediwound's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mediwound's market value can be influenced by many factors that don't directly affect Mediwound's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mediwound's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mediwound is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mediwound's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.